{
    "url_original": "https://www.wsj.com/articles/pfizer-moderna-and-other-drugmakers-make-billions-meeting-covid-19-needs-11645811779?mod=business_lead_pos1",
    "url": "pfizer-moderna-and-other-drugmakers-make-billions-meeting-covid-19-needs-11645811779",
    "title": "Pfizer, Moderna and Other Drugmakers Make Billions Responding to Covid-19 Pandemic",
    "sub_head": "Global sales of Covid vaccines and treatments reported so far top $79 billion",
    "category_1": "Health",
    "time": "2022-02-25 12:56:00",
    "body": "Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.<br />Companies including  Pfizer Inc.  and  Moderna Inc.  so far have reported at least $79 billion in combined global sales of Covid-19 vaccines and treatments for 2021, according to a Wall Street Journal review of recent earnings reports. Diagnostic sales also have been strong for companies including  Abbott Laboratories ,  which had $7.7 billion in Covid-19 test sales last year."
}